Polin L - Search Results

1

Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.

Boinpally RR, Polin L, Zhou SL, Jasti BR, Wiegand RA, White K, Kushner J, Horwitz JP, Corbett TH, Parchment RE. Boinpally RR, et al. Among authors: polin l. Cancer Chemother Pharmacol. 2003 Jul;52(1):25-33. doi: 10.1007/s00280-003-0621-0. Epub 2003 May 9. Cancer Chemother Pharmacol. 2003. PMID: 12739061

2

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH. LoRusso P, et al. Among authors: polin l. Cancer Res. 1990 Aug 15;50(16):4900-5. Cancer Res. 1990. PMID: 2165850

3

Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Biernat LA, Valeriote FA, Corbett TH. Mucci-LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1990 Aug;8(3):253-61. doi: 10.1007/BF00171834. Invest New Drugs. 1990. PMID: 2177044

4

Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.

LoRusso PM, Aukerman SL, Polin L, Redman BG, Valdivieso M, Biernat L, Corbett TH. LoRusso PM, et al. Among authors: polin l. Cancer Res. 1990 Sep 15;50(18):5876-82. Cancer Res. 1990. PMID: 2393858

5

Activity of batracylin (NSC-320846) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Bissery MC, Valeriote F, Plowman J, Luk GD, Corbett TH. Mucci-LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1989 Nov;7(4):295-306. doi: 10.1007/BF00173759. Invest New Drugs. 1989. PMID: 2557298

6

5-Fluorouracil containing combinations in murine tumor systems.

Corbett TH, Bissery MC, Mucci-LoRusso P, Polin L. Corbett TH, et al. Among authors: polin l. Invest New Drugs. 1989 Apr;7(1):37-49. doi: 10.1007/BF00178190. Invest New Drugs. 1989. PMID: 2661481 Review.

7

Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.

Tapazoglou E, Polin L, Corbett TH, al-Sarraf M. Tapazoglou E, et al. Among authors: polin l. Invest New Drugs. 1988 Dec;6(4):259-64. doi: 10.1007/BF00173643. Invest New Drugs. 1988. PMID: 3068184

8

Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Corbett TH, Bissery MC, Wozniak A, Plowman J, Polin L, Tapazoglou E, Dieckman J, Valeriote F. Corbett TH, et al. Among authors: polin l. Invest New Drugs. 1986;4(3):207-20. doi: 10.1007/BF00179586. Invest New Drugs. 1986. PMID: 3546183

9

Skeletal conformations and receptor binding of some 9,11-modified estradiols.

Palomino E, Heeg MJ, Horwitz JP, Polin L, Brooks SC. Palomino E, et al. Among authors: polin l. J Steroid Biochem Mol Biol. 1994 Jul;50(1-2):75-84. doi: 10.1016/0960-0760(94)90174-0. J Steroid Biochem Mol Biol. 1994. PMID: 8049136

10

Comparative efficacy of DMP 840 against mouse and human solid tumor models.

LoRusso P, Demchik L, Dan M, Polin L, Gross JL, Corbett TH. LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1995;13(3):195-203. doi: 10.1007/BF00873800. Invest New Drugs. 1995. PMID: 8729946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters